BEIJING - Pharmaceutical giant AstraZeneca said that the head of its China operations had been detained, after reports the ...

Stay in the know with a recap of our top stories today. 1. AstraZeneca to open new $2b facility in Tuas by 2029, promises 800 ...

Pharmaceutical giant AstraZeneca has confirmed that Leon Wang, the head of its China operations, had been detained.

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous ...

AstraZeneca's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected ...

Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...

AstraZeneca and Eccogene revealed promising trial data on ECC5004, an oral GLP-1 receptor agonist for obesity, showing safety ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former ...

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you ...

Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe ...